Analysis of Combined Hepatocellular Cholangiocarcinomas
Author Information
Author(s): Wachtel Mitchell S., Zhang Yan, Xu Tom, Chiriva-Internati Maurizio, Frezza Eldo E
Primary Institution: Texas Tech University Health Sciences Center
Hypothesis
Analysis of a large database would yield more definite answers regarding combined hepatocellular cholangiocarcinomas.
Conclusion
Combined tumors differ from hepatomas and cholangiocarcinomas in terms of distribution and survival patterns in the population.
Supporting Evidence
- 282 patients had combined tumors, which is a small percentage of the total 22,553 patients studied.
- Men were less likely to have cholangiocarcinomas compared to combined tumors.
- Hepatomas were less likely to present with distant spread than combined tumors.
- Patients with a known Asian or Pacific birthplace were more likely to have hepatomas than combined tumors.
- Among patients without a known Asian/Pacific birthplace, cholangiocarcinomas and hepatomas had better prognoses than combined tumors.
Takeaway
This study looked at a lot of patients with liver tumors to see how combined tumors are different from other types, and found that they behave differently.
Methodology
The study analyzed data from the SEER database, comparing 282 combined tumors with 2,035 intrahepatic cholangiocarcinomas and 19,336 hepatomas using multinomial logit regression and Cox regression.
Limitations
The study could not subclassify combined tumors or account for hepatitis virus serologic studies and the effects of alcohol or drug abuse.
Participant Demographics
The study included 22,553 patients, with 282 having combined tumors, 2,935 having intrahepatic cholangiocarcinomas, and 19,336 having hepatomas.
Statistical Information
P-Value
p<0.025
Confidence Interval
0.49–0.81; 0.43–0.72; 1.17–1.93; 1.56–3.56
Statistical Significance
p<0.025
Want to read the original?
Access the complete publication on the publisher's website